In today’s environment, it is important to make the right R&D choices, especially considering the various pressures on developers such as time, resources, and funding. Short term thinking can lead to long term problems leading to missed timelines, escalating costs, and even regulatory issues in later phases. Fortunately, innovators can employ various data driven scientific approaches to make key early development decisions right the first time.
This event will focus on several key considerations for developing the best small molecule drug product for patients:
We are passionate about helping healthcare startups succeed, and that means more than providing state-of-the-art lab space and equipment. Our resident companies have access to a wealth of Johnson & Johnson resources and internal expertise in pharmaceuticals, medical devices and consumer products— and across all of our therapeutic areas. And because it’s a “no-strings-attached” model, companies gain access to the broader Johnson & Johnson Family of Companies and expertise while retaining intellectual property and decision-making freedom. JLABS is designed to remove hurdles to success and empower life science innovators through infrastructure, community and specialized expertise. Our resident startups build the confidence to reach their entrepreneurial goals and make a lasting difference in the lives of patients. We exist to support you.
